M&A Deal Summary

Encorium Group Acquires Progenitor Holding AG

On July 19, 2010, Encorium Group acquired life science company Progenitor Holding AG for 3M EUR

Acquisition Highlights
  • This is Encorium Group’s 1st transaction in the Life Science sector.
  • This is Encorium Group’s 0th largest (disclosed) transaction.
  • This is Encorium Group’s 1st transaction in Switzerland.

M&A Deal Summary
Date 2010-07-19
Target Progenitor Holding AG
Sector Life Science
Buyer(s) Encorium Group
Deal Type Add-on Acquisition
Deal Value 3M EUR

Target

Progenitor Holding AG

Baar, Switzerland
Progenitor Holding AG is a European headquartered emerging market clinical research organization providing international drug development services in emerging market regions.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Encorium Group

Wayne, Pennsylvania, United States
Category Company
Sector Life Science
DESCRIPTION

Encorium Group Inc. is a full-service Contract Research Organization (CRO) providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Switzerland) 1 of 1
Year (2010) 1 of 1
Mergr

Product

Company

Legal